La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Indans »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Income < Indans < Indazoles  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000273 (2015) Romain Lefaucheur ; Floriane Le Goff ; Gaëlle Gaillon ; Aude Triquenot-Bagan ; David MaltêteSevere dizziness following rivaroxaban introduction in a parkinsonian patient: Drug-drug interaction?
000589 (2014) P. Cesaro ; L. Defebvre[Drug treatment of early-stage (de novo and "honeymoon") Parkinson disease].
000600 (????) Romain Lefaucheur ; Damien Fetter ; Gaëlle Gaillon ; Alaina Borden ; David MaltêteTendon rupture as an adverse effect of rasagiline.
000700 (2013) Fanny Duval ; Olivier Flabeau ; Julien Razafimahefa ; Umberto Spampinato ; François TisonEncephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
000788 (2013) François Viallet ; Séverine Pitel ; Sylvie Lancrenon ; Olivier BlinEvaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson's disease.
000835 (2012) Bruno Dubois ; Eduardo Tolosa ; Regina Katzenschlager ; Murat Emre ; Andrew J. Lees ; Günther Schumann ; Emmanuelle Pourcher ; Julian Gray ; Gail Thomas ; Jina Swartz ; Timothy Hsu ; Margaret L. MolineDonepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.
000960 (2011) Santiago Perez-Lloret ; Olivier RascolSafety of rasagiline for the treatment of Parkinson's disease.
000980 (2011) Olivier Rascol ; Cheryl J. Fitzer-Attas ; Robert Hauser ; Joseph Jankovic ; Anthony Lang ; J William Langston ; Eldad Melamed ; Werner Poewe ; Fabrizio Stocchi ; Eduardo Tolosa ; Eli Eyal ; Yoni M. Weiss ; C Warren OlanowA double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.
000A33 (2010) Olivier Rascol[Disease-modifying therapies in PD].
000D56 (2007) Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
000E26 (2006) Rasagiline. Parkinson's disease: a simple me-too.
000E77 (2006) Joumana Hudry ; Juha O. Rinne ; Tapani Ker Nen ; Laurent Eckert ; John M. CochranCost-utility model of rasagiline in the treatment of advanced Parkinson's disease in Finland.
000F29 (2005) Olivier RascolRasagiline in the pharmacotherapy of Parkinson's disease--a review.
000F59 (????) O. Rascol ; D J Brooks ; E. Melamed ; W. Oertel ; W. Poewe ; F. Stocchi ; E. TolosaRasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
001118 (2003) Olivier RascolMonoamine oxidase inhibitors--is it time to up the TEMPO?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Indans" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Indans" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Indans
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024